AMWL American Well Corporation

Doximity (DOCS), which calls itself the leading digital platform for U.S. medical professionals, has seen its stock fall steeply over the past year. Even after a rise over the past three months, the shares sit about 65% below their 52-week high. Management continued its repurchase program, allocating approximately $401 million over the latest twelve months. The test is whether it can keep that up through what it calls its AI investment year.

Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.

Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.

INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.

American Well is back in focus after analysts lifted fair value estimates from US$8.9 to US$12.8, which points to a higher price target range for the stock. The shift reflects recent research that strikes a more constructive tone, with higher targets clustering around themes such as revenue visibility, cost discipline, and the company’s relationship with the Defense Health Agency. As you read on, you will see how these moving targets shape the evolving analyst narrative and what to watch if...

American Well (AMWL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TDOC's BetterHelp faces a capacity crunch as insurance demand surges, putting therapist recruitment and credentialing at the center.

American Well (AMWL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Losses narrowed 53% as subscriptions grew and costs fell 38% year over year.

American Well Corp (AMWL) reports improved EBITDA and a major government contract win despite a year-over-year revenue decline.

American Well (NYSE:AMWL), which operates as Amwell, reported second-quarter 2026 revenue of $52 million, down 26.6% from a year earlier, while narrowing its adjusted EBITDA loss and raising its full-year profitability outlook as the company pursues operating and cash-flow breakeven in the fourth qu

American Well (AMWL) delivered earnings and revenue surprises of +1.67% and +3.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

A new ChatGPT feature allows users to securely connect personal health data, enabling more personalized, context-aware responses to everyday health questions.

American Well (AMWL) demonstrates strong technical momentum, recently hitting a new 2-year high. Shares are up nearly 57% over the past year. AMWL maintains a 100% “Buy” technical opinion from Barchart. Despite an 18.85% projected revenue decline this year, earnings are expected to rise 16.01% this year and 37.31% next...

American Well (AMWL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.